Ebima Clifford Okundaye
Clinical trials sponsored by Ebima Clifford Okundaye, explained in plain language.
-
New drug QRX-3 aims to speed kidney recovery in hospital patients
Disease control Not yet recruitingThis study tests whether the investigational drug QRX-3 can help hospitalized children and adults with acute tubular necrosis, a type of sudden kidney failure. About 500 participants will receive either QRX-3 or a placebo alongside standard care. The main goal is to see if QRX-3 …
Phase: PHASE2, PHASE3 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug aims to save kidneys: 3,000-Patient trial launches
Disease control Not yet recruitingThis trial tests a new drug called QRX3 in 3,000 people with chronic kidney disease whose kidney function is declining. The goal is to see if QRX3 can improve kidney function and slow the need for dialysis. Participants take QRX3 capsules, and researchers measure changes in kidne…
Phase: PHASE2, PHASE3 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated Jun 26, 2026 14:50 UTC